<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39556251</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1758-1095</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Nov</Month><Day>18</Day></PubDate></JournalIssue><Title>Journal of the Royal Society of Medicine</Title><ISOAbbreviation>J R Soc Med</ISOAbbreviation></Journal><ArticleTitle>Deriving and validating a risk prediction model for long COVID: a population-based, retrospective cohort study in Scotland.</ArticleTitle><Pagination><StartPage>1410768241297833</StartPage><MedlinePgn>1410768241297833</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">01410768241297833</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/01410768241297833</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Using electronic health records, we derived and internally validated a prediction model to estimate risk factors for long COVID and predict individual risk of developing long COVID.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Population-based, retrospective cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Scotland.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Adults (&#x2265;18 years) with a positive COVID-19 test, registered with a general medical practice between 1 March 2020 and 20 October 2022.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Adjusted odds ratios (aORs) with 95% confidence intervals (CIs) for predictors of long COVID, and patients' predicted probabilities of developing long COVID.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 68,486 (5.6%) patients were identified as having long COVID. Predictors of long COVID were increasing age (aOR: 3.84; 95% CI: 3.66-4.03 and aOR: 3.66; 95% CI: 3.27-4.09 in first and second splines), increasing body mass index (BMI) (aOR: 3.17; 95% CI: 2.78-3.61 and aOR: 3.09; 95% CI: 2.13-4.49 in first and second splines), severe COVID-19 (aOR: 1.78; 95% CI: 1.72-1.84); female sex (aOR: 1.56; 95% CI: 1.53-1.60), deprivation (most versus least deprived quintile, aOR: 1.40; 95% CI: 1.36-1.44), several existing health conditions. Predictors associated with reduced long COVID risk were testing positive while Delta or Omicron variants were dominant, relative to when the Wild-type variant was dominant (aOR: 0.85; 95% CI: 0.81-0.88 and aOR: 0.64; 95% CI: 0.61-0.67, respectively) having received one or two doses of COVID-19 vaccination, relative to unvaccinated (aOR: 0.90; 95% CI: 0.86-0.95 and aOR: 0.96; 95% CI: 0.93-1.00).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Older age, higher BMI, severe COVID-19 infection, female sex, deprivation and comorbidities were predictors of long COVID. Vaccination against COVID-19 and testing positive while Delta or Omicron variants were dominant predicted reduced risk.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jeffrey</LastName><ForeName>Karen</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-0061-6089</Identifier><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh EH16 4UX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammersley</LastName><ForeName>Vicky</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh EH16 4UX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maini</LastName><ForeName>Rishma</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Public Health Scotland, Glasgow and Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crawford</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh EH16 4UX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woolford</LastName><ForeName>Lana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh EH16 4UX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batchelor</LastName><ForeName>Ashleigh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh EH16 4UX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weatherill</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh EH16 4UX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh EH16 4UX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Millington</LastName><ForeName>Tristan</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-0260-0515</Identifier><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh EH16 4UX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kerr</LastName><ForeName>Robin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>NHS Borders, Melrose, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basetti</LastName><ForeName>Siddharth</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>NHS Highland, Inverness, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macdonald</LastName><ForeName>Calum</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh EH16 4UX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quint</LastName><ForeName>Jennifer K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kerr</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh EH16 4UX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Syed Ahmar</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0001-5672-0443</Identifier><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh EH16 4UX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurdi</LastName><ForeName>Amanj</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Strathclyde Institute of Pharmacy and Biomedical Science, University of Strathclyde, Glasgow G4 0RE, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, College of Pharmacy, Hawler Medical University, Erbil, Iraq.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Al-Kitab University, Kirkuk 36015, Iraq.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simpson</LastName><ForeName>Colin R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh EH16 4UX, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Health, Wellington Faculty of Health, Victoria University of Wellington, Wellington, New Zealand.</Affiliation><Identifier Source="RINGGOLD">8491</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katikireddi</LastName><ForeName>Srinivasa Vittal</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>Public Health Scotland, Glasgow and Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MRC/CSO Social &amp; Public Health Sciences Unit, University of Glasgow, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rudan</LastName><ForeName>Igor</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh EH16 4UX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robertson</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Public Health Scotland, Glasgow and Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Mathematics and Statistics, University of Strathclyde, Glasgow, UK.</Affiliation><Identifier Source="RINGGOLD">3527</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ritchie</LastName><ForeName>Lewis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Academic Primary Care, University of Aberdeen, Aberdeen, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Applied Health Sciences, University of Aberdeen, Aberdeen AB24 3FX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheikh</LastName><ForeName>Aziz</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7022-3056</Identifier><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh EH16 4UX, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daines</LastName><ForeName>Luke</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0564-4000</Identifier><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh EH16 4UX, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J R Soc Med</MedlineTA><NlmUniqueID>7802879</NlmUniqueID><ISSNLinking>0141-0768</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical</Keyword><Keyword MajorTopicYN="N">epidemiologic studies</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">health informatics</Keyword><Keyword MajorTopicYN="N">infectious diseases</Keyword></KeywordList><CoiStatement>AS reports grants from HDRUK, grants from NIHR, grants from MRC, grants from ICSF, during the conduct of the study; and Member of Scottish Government&#x2019;s CMO COVID-19 Advisory Group and Standing Committee on Pandemics. CR reports support from PHS and MRC. CS reports grants from MBIE (New Zealand), Ministry of Health (New Zealand), and HRC (New Zealand). JKQ reports grants from MRC, HDR UK, GlaxoSmithKline, BI, Asthma+Lung UK and AstraZeneca and consulting fees from GlaxoSmithKline, Evidera, AstraZeneca, Insmed. SVK reports grants from MRC and Scottish Government CSO. KJ, VH, RM, AC, LW, AB, DW, CW, TM, RK, SB, CM, SK, SAS, AK, IR, LR and LD report no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>11</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39556251</ArticleId><ArticleId IdType="pmc">PMC11574934</ArticleId><ArticleId IdType="doi">10.1177/01410768241297833</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023; 21: 133&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Post-COVID-19 Condition (Long COVID). See www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition (last checked 18 July 2023).</Citation></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 2022; 22: e102&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al.. Characterising long COVID: a living systematic review. BMJ Global Health 2021; 6: e005427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O, Stehlik P, Clark J, et al.. Effect of Covid-19 vaccination on long Covid: systematic review. BMJ Med 2023; 2: e000385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, Riley S, Darzi A, Cooke G, et al.. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun 2022; 13: 1957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al.. Attributes and predictors of long COVID. Nat Med 2021; 27: 626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Binka M, Klaver B, Cua G, Wong AW, Fibke C, Vel&#xe1;squez Garc&#xed;a HA, et al.. An elastic net regression model for identifying long covid patients using health administrative data: a population-based study. Open Forum Infect Dis 2022; 9: ofac640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9780702</ArticleId><ArticleId IdType="pubmed">36570972</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessler R, Philipp J, Wilfer J, Kostev K. Predictive attributes for developing Long COVID &#x2013; a study using machine learning and real-world data from primary care physicians in Germany. J Clin Med 2023; 12: 3511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10219004</ArticleId><ArticleId IdType="pubmed">37240616</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff ER, Girvin AT, Bennett TD, Bhatia A, Brooks IM, Deer RR, et al.. Identifying who has long COVID in the USA: a machine learning approach using N3C data. Lancet Digit Health 2022; 4: e532&#x2013;e541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9110014</ArticleId><ArticleId IdType="pubmed">35589549</ArticleId></ArticleIdList></Reference><Reference><Citation>Deforth M, Gebhard CE, Bengs S, Buehler PK, Schuepbach RA, Zinkernagel AS, et al.. Development and validation of a prognostic model for the early identification of COVID-19 patients at risk of developing common long COVID symptoms. Diag Prognostic Res 2022; 6: 1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9668400</ArticleId><ArticleId IdType="pubmed">36384641</ArticleId></ArticleIdList></Reference><Reference><Citation>Epsi NJ, Powers JH, Lindholm DA, Mende K, Malloy A, Ganesan A, et al.. A machine learning approach identifies distinct early-symptom cluster phenotypes which correlate with hospitalization, failure to return to activities, and prolonged COVID-19 symptoms. PLoS One 2023; 18: e0281272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9910657</ArticleId><ArticleId IdType="pubmed">36757946</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeffrey K, Woolford L, Maini R, Basetti S, Batchelor A, Weatherill D, et al.. Prevalence and risk factors for long COVID among adults in Scotland using electronic health records: a national, retrospective, observational cohort study. EClinMed 2024; 71:102590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11016856</ArticleId><ArticleId IdType="pubmed">38623399</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AJ, MacKenna B, Inglesby P, Tomlinson L, Rentsch CT, Curtis HJ, et al.. Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY. Br J Gen Pract 2021; 71: e806&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8340730</ArticleId><ArticleId IdType="pubmed">34340970</ArticleId></ArticleIdList></Reference><Reference><Citation>Knuppel A, Boyd A, Macleod J, Chaturvedi N, Williams DM. The long COVID evidence gap in England. Lancet 2024; 403(10440): 1981&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">38729195</ArticleId></ArticleIdList></Reference><Reference><Citation>Daines L, Mulholland RH, Vasileiou E, Hammersley V, Weatherill D, Vittal Katikireddi S, et al.. Deriving and validating a risk prediction model for long COVID-19: protocol for an observational cohort study using linked Scottish data. BMJ Open 2022; 12: e059385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9260199</ArticleId><ArticleId IdType="pubmed">35793922</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD) the TRIPOD statement. Circulation 2015; 131: 211&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4297220</ArticleId><ArticleId IdType="pubmed">25561516</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulholland RH, Vasileiou E, Simpson CR, Robertson C, Ritchie LD, Agrawal U, et al.. Cohort profile: early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II) database. Int J Epidemiol 2021; 50: 1064&#x2013;1074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8195245</ArticleId><ArticleId IdType="pubmed">34089614</ArticleId></ArticleIdList></Reference><Reference><Citation>Scottish Executive . Scottish index of multiple deprivation: 2006 technical report. 17 Oct 2006. 
Edinburgh: 
Scottish Executive. See www.gov.scot/Resource/Doc/933/0041180.pdf (last checked 1 May 2024).</Citation></Reference><Reference><Citation>Clift AK, Coupland CAC, Keogh RH, Diaz-Ordaz K, Williamson E, Harrison EM, et al.. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study BMJ 2020; 371: m3731.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7574532</ArticleId><ArticleId IdType="pubmed">33082154</ArticleId></ArticleIdList></Reference><Reference><Citation>Ensor J, Martin EC, Riley RD. Pmsampsize: calculates the minimum sample size required for developing a multivariable prediction model. R package version 1.1.3. 6 Dec 2023.</Citation></Reference><Reference><Citation>Hippisley-Cox J, Coupland CA, Mehta N, Keogh RH, Diaz-Ordaz K, Khunti K, et al.. Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study. BMJ 2021; 374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8446717</ArticleId><ArticleId IdType="pubmed">34535466</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet 2022; 399: 2263&#x2013;2264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison K, Cullen L, James AB, Chua V, Sullivan C, Robertson C, et al.. Predictors of incomplete COVID-19 vaccine schedule among adults in Scotland: two retrospective cohort analyses of the primary schedule and third dose. Vaccine 2023; 41: 5863&#x2013;5876.</Citation><ArticleIdList><ArticleId IdType="pubmed">37598025</ArticleId></ArticleIdList></Reference><Reference><Citation>Amele S, McCabe R, Kibuchi E, Pearce A, Hainey K, Demou E, et al.. Quality of ethnicity data within Scottish health records and implications of misclassification for ethnic inequalities in severe COVID-19: a national linked data study. J Public Health 2024; 46: 116&#x2013;122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10901260</ArticleId><ArticleId IdType="pubmed">37861114</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>